CLINICAL TRIAL WEARABLES & SENSORS INSIGHTS
-
Digital Measurement Of Nocturnal Scratch In Atopic Dermatitis
A major challenge in managing atopic dermatitis (AD) is the lack of objective tools to measure the impact of nocturnal scratching, but new digital measurement solutions could address this gap.
-
How Wearable Devices Improve Patient Engagement In Clinical Trials
Wearables are no longer optional—they are foundational to the future of patient-centric, data-driven clinical research.
WEARABLES & SENSORS RESOURCES
-
Dr. Bill Byrom sat with Cardiology Professor Marianna Fontana to discuss opportunities for measuring aspects of health meaningful for increasing the usefulness of COA measures in heart failure trials.
-
To create an effective decentralized clinical trial, tools and methods must be considered within the context of challenges faced by the clinical trial’s patients, physicians, and sites.
-
Learn how by looking at the advantages of wearables and where they are headed in the future, manufacturers, providers, and researchers can better anticipate collaboration efforts to bridge the gaps in existing processes and maximize the potential of eCOA wearables in clinical research.
-
Explore how technological advancements, innovative business models, increased wearables support, FDA’s push to the industry to adopt DCTs, and a holistic approach to clinical trials have proliferated the DCT landscape.
-
Consider how integrated response technologies and electronic clinical outcomes assessments can improve configurability, study start-up, and flexible mid-study changes.
-
In this post, gain insight into five key considerations that will help support patients in China.
-
The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.